Results 91 to 100 of about 149,105 (224)

Colorectal cancer screening awareness among physicians in Greece

BMC Gastroenterology, 2006
Background Data comparison between SEER and EUROCARE database provided evidence that colorectal cancer survival in USA is higher than in European countries.
Chatzimichalis Georgios, Papadopoulos Panagiotis, Sidiropoulou Varvara, Zacharias Georgios, Gkinosati Athanasia, Kamposioras Konstantinos, Mauri Davide, Xilomenos Apostolos, Golfinopoulos Vassilis, Peponi Christina   +9 more
doaj   +1 more source

Association of Regional Variation in Primary Care Physicians’ Colorectal Cancer Screening Recommendations with Individual Use of Colorectal Cancer Screening [PDF]

, 2011
Introduction: Studies show that the recommendations of a primary care physician for colorectal cancer screening may be one important influence on an individual's use of screening. However, another possible influence, the effect of regional differences in
Brawarsky, Phyllis, Brown, Martin L, Fitzmaurice, Garrett, Haas, Jennifer, Hiatt, Robert A, Klabunde, Carrie N, Liang, Su-Ying, Phillips, Kathryn A   +7 more
core  

Risk for colorectal adenomas among patients with pancreatic intraductal papillary mucinous neoplasms: a prospective case-control study [PDF]

, 2015
BACKGROUND AND AIMS: It has been reported that patients with intraductal papillary mucinous neoplasms of the pancreas are at an increased risk of colorectal cancer.
Panic, N, Capurso, G, Attili, F, Vitale, G, Stigliano, S, DELLE FAVE, Gianfranco, Leoncini, E, Bulajic, M, DI GIULIO, Emilio, Costamagna, G, Boccia, S, Larghi, A.   +11 more
core   +1 more source

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer

Molecular Oncology, EarlyView.
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui, Matthew A. Cottam, Muhammad Bilal Mirza, Keeli B. Lewis, Kristen K. Ciombor, Mary Kay Washington, Kamran Idrees   +6 more
wiley   +1 more source

The LEAD trial - the effectiveness of a decision aid on decision making among citizens with lower educational attainment who have not participated in FIT-based colorectal cancer screening in Denmark: study protocol for a randomized controlled trial [PDF]

, 2018
Background: Colorectal cancer screening participation is a preference-sensitive choice, in which trade-offs between benefits and harms must be made by individual citizens.
Andersen, Berit, Edwards, Adrian, Gabel, Pernille, Kirkegaard, Pia, Larsen, Mette Bach   +4 more
core   +3 more sources

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source

Epidemiology of colorectal cancer. [PDF]

, 2016
Colorectal cancer is currently the third deadliest cancer in the United States and will claim an estimated 49,190 U.S. lives in 2016. The purpose of this review is to summarize our current understanding of this disease, based on nationally published ...
Marley, Andrew R., Nan, Hongmei
core   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

The Association Between Screening for Colorectal Cancer and Mental and Physical Health

Cancer Control
Background Colorectal cancer screening reduces colorectal cancer morbidity and mortality. Identifying the factors associated with screening participation is needed to overcome barriers to screening.
Yiting Gong MPH, Louisa B. Flander PhD, Finlay Macrae MD, Carlene Wilson PhD, Mark A. Jenkins PhD   +4 more
doaj   +1 more source

Qualitative Assessment of Washington State Medicaid Health Plan Readiness to Implement Systems-Based Approaches to Colorectal Cancer Screening

Inquiry: The Journal of Health Care Organization, Provision, and Financing, 2019
Implementation of population-based colorectal cancer screening programs by Medicaid health plans could address colorectal cancer screening disparities.
Elizabeth Witwer MPH, Laura-Mae Baldwin MD, MPH, Allison Cole MD, MPH   +2 more
doaj   +1 more source